ClinicalTrials.gg
CompletedNCT00965133Updated Jun 11, 2013

Endurance Training in Young Persons With Cerebral Palsy; Evaluation of Training Method and Effect

An interventional study of Endurance training intervention in Cerebral Palsy, sponsored by Reidun Lauglo. Completed at 1 site in Norway. Open to participants aged 10 Years to 17 Years. Per ClinicalTrials.gov, last updated 2013-06-11.

Sponsored by Reidun Lauglo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Non-randomized
Ages
10 Years to 17 Years
Sex
All
01

Study summary

The hypotheses of the study are that children / youth with CP will by possibly use of technical aids be able to perform high intensity endurance training by walking / running on a treadmill, and that this training will improve their health by increased aerobic capacity and quality of life.

02

Conditions studied

  • Cerebral Palsy

Browse trials for

03

In context

Cerebral Palsy

1,891 studies on the registry are indexed under Cerebral Palsy; 439 are open to participants now.

This study's enrollment of 24 is below the median of 34 across 1,396 interventional studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

This is the only study on the registry with Reidun Lauglo as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Person with CP, GMFCS-level I-IV, age 10-17 years
  • Living in Mid-Norway
  • Wants to increase his / her level of physical activity

Exclusion criteria

Exclusion Criteria:

  • Completes less than 75% of the total number of training sessions
  • Not able to complete the testing and training procedures due to sickness, injury or other physical and psychological conditions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • No intervention
    Normal daily activity

    Other: Endurance training intervention

Interventions

  • OtherEndurance training intervention

    High intensive interval training of walking / running on treadmill for 1 1/2 - 4 minute,repeated minimum 4 times, at an intensity equalling at least 80% of maximal heart frequency. Performed 2-5 times per week for 4-8 weeks, totally 24 sessions.

06

What researchers measure

Primary outcomes

  1. Aerobic capacity

    Time frame: Sept. 2009 - april 2010

Secondary outcomes

  1. Quality of life

    Time frame: Sept. 2009 - April 2010

07

Study locations

1 site
  • Rosenborgklinikken
    Trondheim, Norway
08

References and documents

Publications

  • Lauglo R, Vik T, Lamvik T, Stensvold D, Finbraten AK, Moholdt T. High-intensity interval training to improve fitness in children with cerebral palsy. BMJ Open Sport Exerc Med. 2016 May 9;2(1):e000111. doi: 10.1136/bmjsem-2016-000111. eCollection 2016. PubMed 27900177 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00965133
Lead sponsor
Reidun Lauglo
Responsible party
Reidun Lauglo (Physiotherapist, Reidun Lauglo) — Principal investigator
First posted
Aug 25, 2009
Start date
Sep 2009
Primary completion
Dec 2010
Completion
Feb 2011
Last update
Jun 11, 2013

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion